First-in-human, robotic-assisted neuroendovascular intervention
First-in-human, robotic-assisted neuroendovascular intervention
复制标题
DOI：
10.1136/neurintsurg-2019-015671.rep
复制
发表时间：
2020-04-01
影响因子：
4.8
通讯作者：
Turk, Aquilla
中科院分区：
文献类型：
--
作者：
Pereira, Vitor;Cancelliere, Nicole Mariantonia;Turk, Aquilla
机器人辅助技术已被用作加强开放式和微创手术以及经皮冠状动脉和外周血管介入治疗的工具。它提供了许多潜在的好处，包括增加程序和技术的准确性，以及减少辐射剂量在透视程序。它还为真正的“远程”程序提供了可能性。尽管有这些好处，机器人技术尚未用于神经血管内领域，除了诊断性脑血管造影。在这里，我们报告了第一个机器人辅助的，治疗性的，神经血管内介入治疗在人类身上进行。这是一项支架辅助弹簧圈栓塞术，用于治疗大型基底动脉瘤。所有颅内步骤，包括支架置入和弹簧圈展开，均在CorPath（c）GRX机器人系统（Corindus，Siemens Healthineers Company，Waltham，MA，USA）的辅助下进行。这代表了神经血管疾病治疗的一个重要里程碑，并为远程机器人神经血管内手术的开发打开了大门。
Robotic-assisted technology has been used as a tool to enhance open and minimally invasive surgeries as well as percutaneous coronary and peripheral vascular interventions. It offers many potential benefits, including increased procedural and technical accuracy as well as reduced radiation dose during fluoroscopic procedures. It also offers the potential for truly "remote" procedures. Despite these benefits, robotic technology has not yet been used in the neuroendovascular field, aside from diagnostic cerebral angiography. Here, we report the first robotic-assisted, therapeutic, neuroendovascular intervention performed in a human. This was a stent-assisted coiling procedure to treat a large basilar aneurysm. All intracranial steps, including stent placement and coil deployment, were performed with assistance from the CorPath (c) GRX Robotic System (Corindus, a Siemens Healthineers Company, Waltham, MA, USA). This represents a major milestone in the treatment of neurovascular disease and opens the doors for the development of remote robotic neuroendovascular procedures.